Breast cancer drug Verzenio could have serious side effects on lungs, Japan's health ministry warns

The health ministry on Friday warned that the breast cancer drug Verzenio is now suspected of adversely affecting the lungs after 14 recipients in Japan developed a serious lung disease and three died.

The drug is suspected of causing the side effects in at least four of the 14 cases, including one fatality, the ministry said. Verzenio, developed by Eli Lilly and Co., received Japanese clearance in September last year and debuted in November.

The number of patients in Japan who have used the oral drug since its release is estimated at around 2,000, according to the Health, Labor and Welfare Ministry.

Verzenio is designed to block certain molecules involved in promoting the growth of cancer cells.

• Twitter
• Facebook
• LinkedIn

LATEST NATIONAL STORIES

Tokyo hopes to keep GSOMIA military information-sharing pact with Seoul, Foreign Minister Taro Ko...

In a newspaper interview published in South Korea on Wednesday, Japan's Foreign Minister Taro Kono indicated Tokyo's preference to continue a bilateral accord on sharing military intelligence with ...

Ahead of Upper House vote, Komeito and Abe remain apart on revision of pacifist Constitution

While Prime Minister Shinzo Abe touts constitutional revision as the focal point of Sunday's Upper House election in stump speeches for Liberal Democratic Party candidates, that topic is conspicuou...

Three given prison terms over bogus Tokyo land sale to Sekisui House

Three people were given prison terms Wednesday over a bogus Tokyo land sale in 2017 that targeted home builder Sekisui House Ltd. In the first ruling related to the case, in which 10 people were...